| Literature DB >> 15386477 |
Aharon Levy1, Moshe Kushnir, Shira Chapman, Rachel Brandeis, Zvi Teitelbaum, Eran Gilat.
Abstract
The treatment of organophosphate-induced poisoning is based mainly on atropine and an oxime. Prompt anticonvulsive intervention is usually also required to terminate the ensuing seizure activity and to prevent delayed permanent brain damage. Midazolam, a water-soluble benzodiazepine agonist, has the advantage of rapid absorption following intramuscular administration. In mass casualty situations, the availability of an autoinjector, filled with midazolam, might be a further advantage. In the present study, the plasma pharmacokinetics of midazolam after administration by an autoinjector was compared with conventional intramuscular (i.m.) administration in two groups of four pigs each. During the first 15 min after injection, significantly higher plasma concentrations of midazolam were detected following autoinjector administration, compared with the i.m. injection. The physiological reflection of the accelerated midazolam absorption was a marked reduction in the time interval required for muscle relaxation, induced by midazolam. It is concluded that a midazolam autoinjector might be helpful in the mass casualty scenario following organophosphate poisoning. Copyright (c) 2004 John Wiley & Sons, Ltd.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15386477 DOI: 10.1002/bdd.417
Source DB: PubMed Journal: Biopharm Drug Dispos ISSN: 0142-2782 Impact factor: 1.627